Bladder cancer with bone marrow metastases and thrombotic microangiopathy: a case report

Oxf Med Case Reports. 2024 Jul 30;2024(7):omae081. doi: 10.1093/omcr/omae081. eCollection 2024 Jul.

Abstract

Bladder cancer is one of the most common cancers of the urinary tract and the 10th most common cancer worldwide according to the World Health Organization (WHO), with a higher incidence in men than in women. Bladder cancer rarely presents with a clinical picture of bone marrow infiltration which may result in thrombotic microangiopathy (TMA). TMA is a syndrome triggered by a wide variety of conditions, some of which are associated with cancer. It is a rare condition in patients with solid tumors, the incidence of which is increasing as awareness of this complication improves. Tumor-induced TMA may exhibit a wide spectrum of clinical manifestations. Here we review the case of a 57-year-old male suffering from transitional bladder cancer with bone marrow infiltration that led to TMA Syndrome. We were able to diagnose the cause and treat the patient in a manner that achieved complete remission of symptoms.

Keywords: bladder cancer; bone marrow metastases; thrombotic Microangiopathy (TMA).

Publication types

  • Case Reports